Novavax

Novavax expects to produce 150 million vaccine doses per month as early as May, CEO

Novavax’s stock is going up as its Covid-19 vaccine outperforms J & J’s

Novavax provides first hopeful data on vaccine studies with tests against COVID variants

Novavax provides first hopeful data on vaccine studies with tests against COVID variants

The Novavax vaccine is 89% effective against COVID-19 in a UK study

Novavax says COVID-19 vaccine is 89% effective in UK trial, less in South Africa, stocks jump

Novavax vaccine is 89% effective against Covid-19 in UK study

Novavax sees some loss of COVID-19 vaccine study as Pfizer and Moderna rollout accelerates

Novavax bosses cash in on $ 46 million with COVID-19 vaccine trials still ongoing

Covid-19 vaccines are expected to work on the coronavirus strain in South Africa